Anchiano Therapeutics Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced net loss was USD 3.481 million compared to USD 4.439 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.12 a year ago. For the half year, net loss was USD 7.016 million compared to USD 14.352 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to USD 0.45 a year ago.